409: BARICITINIB VERSUS TOCILIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19. (15th December 2022)

Record Type:: Journal Article
Title:: 409: BARICITINIB VERSUS TOCILIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19. (15th December 2022)
Main Title:: 409: BARICITINIB VERSUS TOCILIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19
Authors:: Lewis-Wolfson, Temeka
Joyner, Kayla
Reid, Nancy
Abstract:
Is Part Of:: Critical care medicine. Volume 51(2023)Supplement 1
Journal:: Critical care medicine
Issue:: Volume 51(2023)Supplement 1
Issue Display:: Volume 51, Issue 1 (2023)
Year:: 2023
Volume:: 51
Issue:: 1
Issue Sort Value:: 2023-0051-0001-0000
Page Start:: 191
Page End:: 191
Publication Date:: 2022-12-15
Subjects:: Critical care medicine -- Periodicals
Soins intensifs -- Périodiques
616.028
Journal URLs:: http://journals.lww.com/ccmjournal/Pages/default.aspx ↗
http://journals.lww.com ↗
DOI:: 10.1097/01.ccm.0000907364.81722.66 ↗
Languages:: English
ISSNs:: 0090-3493
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3487.451000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 24876.xml